Press "Enter" to skip to content

New patent expiration for Ucb Inc drug BRIVIACT

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Ucb Inc drug BRIVIACT

Annual Drug Patent Expirations for BRIVIACT
Annual Drug Patent Expirations for BRIVIACT

Briviact is a drug marketed by Ucb Inc and is included in three NDAs. It is available from one supplier. There are four patents protecting this drug.

BRIVIACT drug price trends.

Drug patent litigation for BRIVIACT.

This drug has one hundred and sixty-two patent family members in forty-five countries.

The generic ingredient in BRIVIACT is brivaracetam. One supplier is listed for this compound. Additional details are available on the brivaracetam profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Ucb Inc drug BRIVIACT
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions